Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin User montaukwhaler, in the non small cell lung cancer subreddit, 16 May 2017